Wuxi Biologics Cayman Inc. buy ValuationRange61
Start price
19.02.25
/
50%
€2.95
Target price
19.03.25
-
Performance (%)
9.15%
End price
20.03.25
€3.22
Summary
This prediction ended on 20.03.25 with a price of €3.22. With a performance of 9.15%, the BUY prediction by ValuationRange61 for Wuxi Biologics Cayman Inc. closed with a slight gain. ValuationRange61 has 50% into this predictionWuxi Biologics is a China-based company that provides biological research and development, testing, and manufacturing services for pharmaceutical companies worldwide. The company offers a wide range of services including integrated discovery and development services, clinical trial services, and commercial manufacturing of biologics. Wuxi Biologics has state-of-the-art facilities in China and the United States, and has established partnerships with leading global biopharmaceutical companies. The company's mission is to become the premier global biologics solutions provider, and it has been recognized for its innovation and excellence in the industry.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Wuxi Biologics Cayman Inc. | -3.156% | -3.156% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by ValuationRange61 for this prediction
In the thread Trading Wuxi Biologics (cayman) Inc.
Die von ValuationRange61 gewählte maximale Laufzeit wurde überschritten